The United States Heart Defect Closure Device market represents the largest share in North America, driven by increasing cases of congenital heart abnormalities including atrial septal defect (ASD), ventricular septal defect (VSD), and patent foramen ovale (PFO), alongside growing adoption of minimally invasive structural heart procedures. The country’s advanced healthcare...